DK0758890T3 - Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne - Google Patents

Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne

Info

Publication number
DK0758890T3
DK0758890T3 DK95918128T DK95918128T DK0758890T3 DK 0758890 T3 DK0758890 T3 DK 0758890T3 DK 95918128 T DK95918128 T DK 95918128T DK 95918128 T DK95918128 T DK 95918128T DK 0758890 T3 DK0758890 T3 DK 0758890T3
Authority
DK
Denmark
Prior art keywords
migraine
treatment
catchers
antagonists
inhibitors
Prior art date
Application number
DK95918128T
Other languages
Danish (da)
English (en)
Inventor
Jes Olesen
Original Assignee
Jes Olesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jes Olesen filed Critical Jes Olesen
Application granted granted Critical
Publication of DK0758890T3 publication Critical patent/DK0758890T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK95918128T 1994-05-11 1995-05-10 Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne DK0758890T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94610027 1994-05-11
EP95918128A EP0758890B1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
PCT/IB1995/000415 WO1995031195A1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Publications (1)

Publication Number Publication Date
DK0758890T3 true DK0758890T3 (da) 2005-04-18

Family

ID=8218183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918128T DK0758890T3 (da) 1994-05-11 1995-05-10 Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne

Country Status (12)

Country Link
US (1) US6265441B1 (enExample)
EP (1) EP0758890B1 (enExample)
JP (2) JPH10500129A (enExample)
AT (1) ATE291909T1 (enExample)
AU (1) AU704059B2 (enExample)
CA (1) CA2189762C (enExample)
DE (1) DE69534118T2 (enExample)
DK (1) DK0758890T3 (enExample)
ES (1) ES2238074T3 (enExample)
PT (1) PT758890E (enExample)
SI (1) SI0758890T1 (enExample)
WO (1) WO1995031195A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270531C (en) * 1996-11-05 2011-08-30 Head Explorer Aps A method for treating tension-type headache
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
AU1824300A (en) * 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (en) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
US20090191283A1 (en) * 2008-01-24 2009-07-30 Oronsky Bryan Todd Treatment of headaches, neck pain, joint pain and inflammatory-type pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2707494B1 (fr) 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
SK16396A3 (en) * 1993-08-12 1996-09-04 Astra Ab Amidine derivatives with nitric oxide synthetase activities
GB9317686D0 (en) 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
EP0759027B1 (en) * 1994-05-07 1999-08-04 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase

Also Published As

Publication number Publication date
EP0758890A1 (en) 1997-02-26
US6265441B1 (en) 2001-07-24
AU704059B2 (en) 1999-04-15
SI0758890T1 (enExample) 2005-08-31
JPH10500129A (ja) 1998-01-06
CA2189762A1 (en) 1995-11-23
CA2189762C (en) 2009-01-13
JP2007137906A (ja) 2007-06-07
AU2417995A (en) 1995-12-05
ES2238074T3 (es) 2005-08-16
DE69534118T2 (de) 2006-02-09
EP0758890B1 (en) 2005-03-30
DE69534118D1 (de) 2005-05-04
PT758890E (pt) 2005-06-30
ATE291909T1 (de) 2005-04-15
WO1995031195A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
NO20032848D0 (no) Substituerte triazoldiaminderivater som kinaseinhibitorer
HRP20000292B1 (hr) 2-fenil supstituirani imidazotriazinoni kao inhibitori fosfodiesteraze
DK0804196T3 (da) Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
DE59707502D1 (de) Holzschutzmittel für den nachschutz
ATE217321T1 (de) Aromatische heterocyclische derivate als enzyminhibitoren
EA200000768A1 (ru) ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
EA199800667A1 (ru) Новые фенантридины
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ATE247470T1 (de) Neue substituierte imidazolverbindungen
FI945411A0 (fi) Viilentäviä koostumuksia
DK1362047T3 (da) Indazolylsubstituerede pyrrolinforbindelser som kinaseinhibitorer
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
ATE266399T1 (de) Neue substituierte triazolverbindungen
ATE214276T1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
EP0787016A4 (en) SECRETORY LEUCOCYTE PROTEASE INHIBITOR USED AS TRYPTASE INHIBITOR
DK0758890T3 (da) Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
AR028730A1 (es) Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxis de la obesidad y utilizacion de dichos compuestos
ES2146249T3 (es) Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2.
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
EA200300978A1 (ru) Ингибирование поглощения моноамина
NO984245L (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
EA199800858A1 (ru) Способ лечения насморка или аллергического ринита